SPARC raises over Rs 1,110 cr; issues warrants to promoter Dilip Shanghvi, others

SPARC raises over Rs 1,110 cr; issues warrants to promoter Dilip Shanghvi, others
PTI
Share
Font Size
Save
Comment
Synopsis

The issue price includes the warrant subscription price (Rs. 44.50 per warrant) and the warrant exercise price (Rs. 133.50 per warrant).

Agencies
The company had initially planned to raise Rs 1,200 crore.

Related

NEW DELHI: (SPARC) on Thursday said it has raised over Rs 1,112 crore by way of issuing warrants to the company's promoter Dilip Shanghvi and other entities.

"The securities allotment committee of the board of directors of the company, has considered and approved the allotment of 6,24,74,082 warrants on preferential basis at an issue price of Rs 178 each aggregating to Rs 1,112.03 crore to Dilip Shantilal Shanghvi, promoter of the company and to certain other non-promoter persons/ entities," SPARC said in a regulatory filing.

The issue price includes the warrant subscription price (Rs. 44.50 per warrant) and the warrant exercise price (Rs. 133.50 per warrant).

Did you Know?

Stock score of Sun Pharma Advanced Research Co Ltd moved up by 1 in 3 months on a 10-point scale.

View Latest Stock Report »

The company had initially planned to raise Rs 1,200 crore.

"As against the approval for issue of 6,74,70,203 warrants, the committee has allotted only 6,24,74,082 warrants, due to, non-receipt of warrant subscription money by the proposed allottees and / or non- receipt of in-principle approval from the stock exchanges on some warrants," the company added.

The company said it has issued 3,37,07,865 out of the total 6,24,74,082 warrants to Shanghvi. Shares of SPARC were trading 2.42 per cent higher at Rs 252.30 apiece on BSE.

Read More News on

(What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)

Download The Economic Times News App to get Daily Market Updates & Live Business News.

ETPrime stories of the day

Read before you invest. Insights on Sun Pharma Advanced Research Company Ltd.. Explore Now